Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting

Presentations review clinical results of 10 kHz Therapy™ for the treatment of chronic back and leg pain, non-surgical back pain (NSBP), and painful diabetic neuropathy (PDN) REDWOOD CITY, Calif., Jan. 17, 2024 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company…

Click here to view original post